Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
129.0 GBX -1.00 ( 0.77%)
Last update at 2026-10-27T16:21:00Z
VOLUME
10058
Market Cap
42.47M
P/E
18.25

Momentum Score

…

AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
125.00
Low
135.00
High
52 Week Price Range
25.00
Low
99.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
130.00
Dividend Yield
-
Revenue TTM
66.54M
Revenue Per Share
0.63
Gross Profit TTM
58.22M
Debt / Equity
0.51
ROE
14.27%
Net Debt
-0.41M
ROCE
3.24%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.94M -7.65M 2.26M -0.08M
Net income -1.76M -8.19M 1.74M -0.09M
Gross profit 51.35M 37.59M 2.86M 0.05M
Reconciled depreciation 1.73M 1.42M 0.65M 0.41M
Ebit 0.91M -5.70M -0.07M 3.49M
Ebitda 2.64M -4.28M 0.48M 3.58M
Depreciation and amortization 1.73M 1.42M 0.55M 0.09M
Operating income 1.25M -5.54M 2.29M -0.08M
Other operating expenses 57.10M 49.45M 6.57M 0.97M
Interest expense 1.85M 1.95M 1.34M 0.03M
Tax provision 0.81M 0.54M 1.29M 1.12M
Net interest income -1.85M -1.95M -1.34M -0.03M
Income tax expense 0.81M 0.54M 0.52M 0.00M
Total revenue 58.36M 43.92M 8.86M 0.89M
Total operating expenses 50.10M 43.13M 0.57M 0.12M
Cost of revenue 7.00M 6.32M 6.00M 0.84M
Total other income expense net -2.20M -2.11M -1.34M -0.04M
Net income from continuing ops -1.76M -8.19M -2.80M 2.03M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 39.54M 21.08M 9.35M 1.51M
Intangible assets 9.02M 9.42M 9.80M 0.19M
Other current assets 0.02M 0.04M 0.24M 0.25M
Total liab 22.10M 26.99M 5.94M 1.25M
Total stockholder equity 17.44M -5.91M 3.41M 0.26M
Other current liab 9.69M 6.43M 5.27M -0.52M
Common stock 0.00M 0.00M 2.16M 0.35M
Capital stock 0.00M 0.00M 0.00M 0.00M
Retained earnings -17.65M -15.89M 1.25M -0.10M
Other assets - - 0.00M -
Cash 9.34M 0.78M 2.56M 0.22M
Total current liabilities 11.52M 13.11M 2.29M 0.55M
Current deferred revenue - - 0.52M 0.00M
Net debt -0.41M 11.57M 1.89M 0.59M
Short term debt 0.19M 0.29M 0.38M 0.27M
Short long term debt - 0.00M 0.20M 0.23M
Short long term debt total 8.92M 12.35M 4.45M 0.81M
Other stockholder equity 35.09M 9.98M 11.11M 1.62M
Total current assets 26.68M 8.34M 3.65M 0.35M
Net receivables 14.82M 5.32M 4.04M 2.42M
Long term debt 8.43M 11.70M 11.60M 0.00M
Inventory 2.51M 2.20M 0.27M 0.03M
Accounts payable 1.55M 5.79M 0.95M 0.79M
Non currrent assets other 0.03M 0.03M -9.80M -0.19M
Non current assets total 12.86M 12.74M 5.70M 1.16M
Capital lease obligations 0.49M 0.66M 0.61M 0.04M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities -1.94M -1.59M -1.23M -0.39M
Net borrowings -4.00M -0.20M 11.55M -0.69M
Total cash from financing activities 16.41M -0.20M 0.65M 0.49M
Net income -1.76M -8.19M 1.74M -0.09M
Change in cash 8.56M -3.24M 2.34M -1.09M
Begin period cash flow 0.78M 4.01M 0.22M 1.31M
End period cash flow 9.34M 0.78M 2.56M 0.22M
Total cash from operating activities -5.91M -1.45M 2.77M -0.05M
Issuance of capital stock 24.73M 0.00M - -
Depreciation 1.73M 1.42M 0.55M 0.09M
Other cashflows from investing activities - 0.87M -0.23M -0.01M
Dividends paid - 1.44M 0.46M -
Change to inventory -0.31M -0.23M -0.12M -0.03M
Change to account receivables -10.00M -1.03M -0.54M -0.09M
Other cashflows from financing activities -4.33M 1.44M -0.14M -
Capital expenditures 1.94M 1.32M 1.00M 0.38M
Change in working capital -11.71M 3.86M -0.03M -0.05M
Stock based compensation 5.18M 1.52M 1.23M 0.00M
Other non cash items 0.64M -0.05M 1.64M 0.24M
Free cash flow -7.85M -2.76M 1.77M -0.43M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AOTI
AOTI Inc
-1.00
0.77%
129.00 18.25 8.10 0.64 2.76 0.94 8.31
SN
Smith & Nephew PLC
-14.00
1.23%
1122.50 23.24 12.47 1.70 2.59 2.67 10.76
NIOX
NIOX Group PLC
2.00
2.99%
69.00 28.20 18.73 4.84 3.41 4.35 13.85
EKF
EKF Diagnostics Holdings Plc
-0.40
1.61%
24.40 - 34.97 2.02 1.46 1.72 7.01
CREO
Creo Medical Group PLC
-
-%
11.25 - - 199.36 0.74 6.21 8.16

Profile*

AOTI Inc

AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.

3512 Seagate Way, Oceanside, CA, United States, 92056

760-431-4700

85

Name Title Year Born
Dr. Michael Griffiths CRT, DMS President, CEO & Director 1967
Mr. Jayesh Pankhania CFO & Director 1970
Mr. Darron Daly Executive Vice President of Marketing & Professional Relations NA
Ms. Gina So'oto Executive Vice President of Global Human Resources NA
Dr. Matthew G. Garoufalis CWS, DPM, FFPM Chief Medical Officer NA
Mr. David Hammond President of Commercial International NA
Mr. Marty Sylvain Chief Advocacy Officer NA
Ms. Stacy Reel Chief Commercial Officer NA
Mr. Robbie Walsh Executive Vice President of Quality & Regulatory Affairs NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…